Pay in 4 interest-free payments of $2.50 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
CRV431 (Rencofilstat) is Hepion Pharmaceuticals' lead drug candidate
like neurological disorders
Change Foods relies heavily on its key partnerships and relationships
Downtime Mitigation: Reduces potential revenue loss
only €3-4m incremental capex needed to maintain production and R&D inputs
BEN FRANKLIN TECHNOLOGY PARTNERS OF SOUTHEASTERN PENNSYLVANIA BCG MATRIX TEMPLATE RESEARCH B_81 CRV431 (Rencofilstat) is Hepion Pharmaceuticals'What is included in the product Detailed Word Document Tailored analysis for the featured companys product portfolio. Customizable Excel Spreadsheet Printable summary optimized for A4 and mobile PDFs. Relieving communication pain points in clear format! Preview = Final Product Ben Franklin Technology Partners of Southeastern Pennsylvania BCG Matrix The BCG Matrix preview you're seeing is the complete document you'll receive immediately after purchase.
US$ 20.00
US$ 12.00
US$ 15.00
US$ 14.00
US$ 17.00
US$ 4974.50
US$ 4249.50
US$ 68.00
US$ 20.00
